Philips stock dips after JP Morgan reiterates Neutral rating

Published on 09/09/2026 at 18:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Philips stock closed at USD 25.29 on September 8, 2026 on the NYSE, down 2.24 percent from the previous session. Analysts’ consensus now points to an average target of EUR 27.00 for the shares, implying upside versus the latest Euronext Amsterdam close.

Fotorealistische Fertigungshalle für Medizintechnik mit Ingenieuren an Scanner-Geräten — Koninklijke Philips N.V. (NL0000009538) zeigt moderne Medizintechnik-Fertigung mit Ingenieuren an High-Tech-Scanner-Anlagen in heller Halle, Illustration mit AI erstellt.

Koninklijke Philips N.V. stock (ISIN NL0000009538) ended the September 8, 2026 session on its primary NYSE listing at USD 25.29, a decline of 2.24 percent compared with the prior close as market data show the shares continuing to trade below their recent highs. Price data for the New York listing indicate that volume reached 29,883 shares on September 8, 2026, with the stock moving between an intraday low of USD 25.28 and a high of USD 25.60 during the session.

JP Morgan keeps Philips stock at Neutral

As MarketScreener reports on September 9, 2026, JP Morgan has reaffirmed its Neutral stance on Philips stock while the shares trade at around EUR 21.73 on Euronext Amsterdam in intraday dealings. According to MarketScreener, the latest previous closing price on the Amsterdam exchange stood slightly higher at EUR 21.86, so the intraday quote on September 9, 2026 reflects a modest decline of about 0.59 percent and leaves the stock down 4.99 percent year to date. The Neutral rating signals that JP Morgan currently sees neither a clear catalyst for outperformance nor a pressing reason to underweight the shares, a stance that can keep short-term moves more driven by news flow and sector sentiment than by rating changes alone.

Consensus figures compiled by MarketScreener on September 9, 2026 show that 20 analysts now cover Philips, with an average recommendation in the Accumulate band and an average price target of EUR 27.00. With the last Euronext Amsterdam close at EUR 21.86, this consensus target implies potential upside of about 23.5 percent if the company can deliver on its medium term plan. The same overview highlights a maximum target of EUR 35.00 and a minimum of EUR 23.40, which translates into a range from roughly 7 percent to more than 60 percent above the last close, underlining how divided analyst expectations remain around the pace of margin recovery and growth in Philips’ health technology portfolio.

Analyst expectations and risk balance

From an investor perspective, the gap between the current trading level and the average target underscores that the market is still pricing in execution risk despite the overall Accumulate consensus. According to the analyst survey on MarketScreener, the divergence between maximum and minimum price objectives reflects differing views on how quickly Philips can expand profitability and return to a more robust growth trajectory relative to its medical technology peers. With the shares still around 4.99 percent below their level at the start of 2026 on Euronext Amsterdam and down 4.89 percent year to date on the CBOE quote for the NYSE listing, the valuation leaves room for positive surprises but also indicates that not all legacy issues are seen as fully resolved.

In the near term, one key operational focus for Philips is the performance of its advanced medical equipment and health technology segments, which drive both growth and margin quality in the broader portfolio. Sector overviews from MarketScreener place Philips within the advanced medical equipment and technology group, where competitive pressure, product cycles and regulatory scrutiny can all affect pricing power. For investors, the balance between innovation spending and margin protection in these segments remains a central theme when assessing whether the stock deserves its Accumulate consensus or something closer to JP Morgan’s more cautious Neutral view.

Stock performance and market levels

On the New York listing, trading data collated by MarketScreener show that Philips stock closed at USD 25.29 on September 8, 2026 after having traded at higher levels earlier in the month, including a closing price of USD 26.59 on September 1, 2026. Over this short interval, the shares have slipped by about USD 1.30, which corresponds to a decline of approximately 4.9 percent, illustrating how quickly sentiment can shift in response to sector moves and company specific headlines. On that same September 8, 2026 session, the stock opened at USD 25.56 and reached an intraday high of USD 25.60 before easing back to the USD 25.29 close, with volume figures around 29,883 shares reinforcing that the move occurred in a relatively modest trading environment.

In euro terms on Euronext Amsterdam, Philips stock traded at around EUR 21.73 in real time on September 9, 2026 compared with the previous close of EUR 21.86, marking a 0.59 percent intraday decline and leaving the shares roughly 6.54 percent below their level a year ago according to the same MarketScreener overview. For investors comparing venues, it is important to note that the NYSE price of USD 25.29 and the Euronext Amsterdam price near EUR 21.73 reflect the same underlying Philips equity but are quoted in different currencies and markets, with daily percentage moves always measured against the prior close on the respective exchange.